Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Clin Genitourin Cancer ; 16(2): e327-e333, 2018 04.
Article in English | MEDLINE | ID: mdl-29361425

ABSTRACT

BACKGROUND: Cardiac metastases from renal cell carcinoma (RCC) are uncommon and there are limited data regarding the presentation and outcomes of this population. The objective of this study was to evaluate the characteristics and outcomes of patients with RCC with cardiac metastasis without inferior vena cava (IVC) involvement. MATERIALS AND METHODS: We conducted a pooled retrospective analysis of metastatic RCC patients treated in 4 clinical trials. Additionally, we conducted a systematic review of cases reported in the literature from 1973 to 2015. Patients with cardiac metastases from RCC without IVC involvement were included. Patient and disease characteristics were described. Additionally, treatments, response to therapy, and survival outcomes were summarized. RESULTS: Of 1765 metastatic RCC patients in the clinical trials database, 10 had cardiac metastases without IVC involvement. All patients received treatment with targeted therapy. There was 1 observed partial response (10%) and 6 patients showed stable disease (60%). The median progression-free survival was 6.9 months. The systematic review of reported clinical cases included 39 patients. In these patients, the most common cardiac site of involvement was the right ventricle (51%; n = 20). Patients were treated with medical (28%; n = 11) and/or surgical treatment (49%; n = 19) depending on whether disease was isolated (n = 13) or multifocal (n = 26). CONCLUSION: To our knowledge, this is the first series to report on the presentation and outcomes of patients with cardiac metastasis without IVC involvement in RCC. We highlight that although the frequency of patients with cardiac metastases without IVC involvement is low, these patients have a unique clinical presentation and warrant special multidisciplinary management.


Subject(s)
Carcinoma, Renal Cell/drug therapy , Heart Neoplasms/drug therapy , Heart Neoplasms/secondary , Kidney Neoplasms/drug therapy , Molecular Targeted Therapy/methods , Adult , Aged , Carcinoma, Renal Cell/surgery , Clinical Trials as Topic , Female , Heart Neoplasms/surgery , Humans , Kidney Neoplasms/surgery , Male , Middle Aged , Progression-Free Survival , Retrospective Studies , Survival Analysis , Treatment Outcome , Vena Cava, Inferior/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...